50-year Wall Street legend: “Sell this tech stock NOW”

Something very strange is happening to U.S. stocks following President Trump's victory... And this could spell disaster for some of America's favorite tech companies.

You can watch for it for free, right here.

Pam Cheng Biography and Net Worth

EVP of Operations & Information Technology and Member of External Sustainability Advisory Board of AstraZeneca

Pam P. Cheng serves as Executive Vice President - Operations and Information Technology of the Company. She spent 18 years with Merck/MSD in Global Manufacturing and Supply Chain and Commercial roles. Pam was the Head of Global Supply Chain Management & Logistics for Merck from 2006 to 2011 and led the transformation of Merck supply chains across the global supply network. More recently, Pam was President of MSD China, responsible for MSD’s entire business in China. Prior to joining Merck, Pam held various engineering and project management positions at Universal Oil Products, Union Carbide Corporation and GAF Chemicals. Pam holds Bachelor’s and Master’s degrees in chemical engineering from Stevens Institute of Technology in New Jersey and an MBA in marketing from Pace University in New York. In addition to her role at AstraZeneca, Pam serves as a Non-Executive Director of the Codexis, Inc. Board. Pam also serves as an Advisor to the International Society of Pharmaceutical Engineering (ISPE) Board of Directors.

How old is Pam P. Cheng?: Ms. Cheng is currently 54 years old. There are 3 older executives and no younger executives at AstraZeneca. The oldest executive at AstraZeneca is Mr. Pascal Soriot D.V.M., M.B.A., CEO & Executive Director, who is 65 years old. Learn More on Pam P. Cheng's age.
How do I contact Pam P. Cheng?: The corporate mailing address for Ms. Cheng and other AstraZeneca executives is 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS, CAMBRIDGE X0, CB2 0AA. AstraZeneca can also be reached via phone at 442037495000 and via email at [email protected]. Learn More on Pam P. Cheng's contact information.
Has Pam P. Cheng been buying or selling shares of AstraZeneca?: Pam P. Cheng has not been actively trading shares of AstraZeneca within the last three months. Learn More on Pam P. Cheng's trading history.
Who are AstraZeneca's active insiders?: AstraZeneca's insider roster includes Katarina Ageborg (EVP of Sustainability), Pam Cheng (EVP of Operations & Information Technology and Member of External Sustainability Advisory Board ), Marc Dunoyer (CEO of Alexion & Chief Strategy Officer ), Menelas Pangalos (EVP ), Aradhana Sarin (CFO & Exec. Director ), and Pascal Soriot (Executive Director and Chief Executive Officer ). Learn More on AstraZeneca's active insiders.

Pam P. Cheng Insider Trading History at AstraZeneca

Pam P. Cheng Buying and Selling Activity at AstraZeneca

AstraZeneca Company Overview

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

Today's Range

Now: $65.63

$65.57

$66.46

50 Day Range

MA: $73.44

$63.20

$79.58

2 Week Range

Now: $65.63

$60.47

$87.68

Volume

7,161,406 shs

Average Volume

5,326,333 shs

Market Capitalization

$203.49 billion

P/E Ratio

31.40

Dividend Yield

1.54%

Beta

0.47